Navigation Links
Leading Epilepsy Advocates Propose Strategies to Heighten Treatment Expectations and Close Patient and Physician Communication Gaps
Date:3/28/2008

National survey reveals room for improvement in balancing seizure control

and medication-related side effects

WASHINGTON, March 28 /PRNewswire/ -- On the heels of the nation's largest event dedicated to the epilepsy community, the National Walk for Epilepsy, advocates today announced their recommendations in response to a new national survey uncovering key challenges facing the epilepsy community. Challenges include gaps in patient-physician communication around medication-related side effects and low public awareness of epilepsy.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080328/CLF099)

According to the survey, sponsored by ORTHO-McNEIL NEUROLOGICS(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., 75 percent of epilepsy patients experience medication-related side effects and for the majority, these impact their daily lives, including 57 percent who say work or school are affected. A disconnect exists between patients and healthcare professionals surrounding their discussions on these side effects. While 98 percent of physicians report discussing medication-related side effects with patients, less than half (47 percent) of epilepsy patients report these discussions take place. And, more than one-quarter of patients report they sometimes feel reluctant to broach this topic during office visits. Not surprisingly, healthcare professionals underestimate the number of patients experiencing medication-related side effects, estimating this figure at just 43 percent. The most common side effects according to the survey are fatigue, poor memory, weight gain or weight loss and loss of concentration.

"These findings suggest treatment expectations among epilepsy patients are simply too low. According to the survey, 61 percent of people with epilepsy believe that side effects are just something they have to live with," said roundtable moderator and Epilepsy Foundation CEO and President Eric Hargis. "People with epilepsy should be proactive in discussing their treatment plans, opening up about the side effects they experience and sharing how these side effects are affecting their lives."

Panelists at the nine-person roundtable included some of the nation's premiere epileptologists, patients and caregivers and celebrity advocates, including Greg Grunberg, star of NBC's television series "Heroes" and father of a son with epilepsy, and New York Giants defensive back Geoffrey Pope whose grandmother has epilepsy.

Improving Treatment Plans

Roundtable participants agreed that people with epilepsy and healthcare professionals should work together to ensure treatment plans are tailored to the individual. According to the survey, 85 percent of patients would prefer to have a more active role in making their treatment decisions.

"It is crucial for patients to speak up and be a part of developing their treatment model," said Georgia Montouris, M.D., director of epilepsy services at the Boston University School of Medicine and Boston Medical Center.

Healthcare professionals surveyed say they would recommend an alternative treatment plan at least half the time for those patients experiencing medication-related side effects. "We need to increase the focus on individualizing treatment plans and strive for optimal balance between seizure control and minimization of side effects so that we can improve the overall well-being of people with epilepsy," added Dr. Montouris.

Roundtable participant Caitlin Purcell, 17, explained how her healthcare professional started her on one medication, but when she was still experiencing seizures he added new medications to her regime to help her further manage her condition. Physicians often try a variety of therapy mixes to customize the treatment approach, "and Caitlin's physician was trying to find the right 'cocktail' for her," noted Dr. Mark Spitz, head of the Adult Comprehensive Epilepsy Program at the University of Colorado.

Participants also discussed the need for new treatments. "We need to continue funding research and development as there is a need for drugs that help us better straddle this balance until a cure for epilepsy can be found," said Hargis.

Other recommendations for improving communication and treatment plans included:

-- Patients and caregivers should advocate for themselves and discuss

their treatment plans, side effects and what other steps can be taken

with their healthcare professionals. "As long as there is seizure

activity, there are still things that can be done or treatments that

can be tried," said Grunberg.

-- Patients should strive for a more individualized treatment plan by

sharing a daily diary or record of how they are feeling, any medication

side-effects or breakthrough seizures they experience with their

healthcare professional.

-- Patients and caregivers, as well as healthcare professionals, should

raise their standards and not settle if the patient is still

experiencing seizures or side effects. "It's not a trade-off. We may

not be able to get every patient to the point of experiencing no

seizures and no side effects, but we should never stop trying," said

Dr. Montouris.

-- Finally, panelists encouraged patients to not hesitate to seek a second

opinion when patients are not achieving their treatment goals.

Raising Public Awareness of Epilepsy

According to the survey, three-quarters of people with epilepsy and 90 percent of physicians feel that the general public is not well-informed about epilepsy. Roundtable participants agreed that this is a major cause for the stigma surrounding epilepsy and some shared their stories of how this has impacted their lives.

"The other kids (in school) are sometimes afraid of me. And sometimes even if they want to have me over after school, their parents are afraid, especially if they haven't seen me have a seizure," explained 14-year-old panelist Carly Richards of Chicago.

Participants addressed the need for continued public education programs that focus on eliminating stigma associated with epilepsy, such as the March 29th annual National Walk for Epilepsy. The panelists encouraged all people who have epilepsy or know someone with the condition to speak out and share their experiences.

"We are at a tipping point for bringing epilepsy out in the open," said Grunberg. "We need to continue the dialogue we started here today to increase awareness and break down the stigma that is unfairly associated with this disorder."

The roundtable, which took place in Washington, D.C. on Friday, March 28, was hosted by the Epilepsy Foundation and ORTHO-McNEIL NEUROLOGICS(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Please visit: http://www.epilepsyfoundation.org to find more information about upcoming 2008 initiatives resulting from the roundtable discussion.

About the Survey

Richard Day Research fielded a survey to epilepsy patients and healthcare professionals. Data from both audiences were collected in January 2008. Healthcare professional data included 459 healthcare professionals -- comprised of 155 primary care physicians (family, general, or internal medicine) and 304 neurologists. Patient data included 414 people diagnosed with epilepsy, screened for having seen a healthcare professional for epilepsy within the last two years.

About the Epilepsy Foundation

The Epilepsy Foundation, a national nonprofit with affiliated organizations throughout the United States, has led the fight against epilepsy since 1968. The Foundation's goals are to ensure that people with seizures are able to participate in all life experiences; and prevent, control and cure epilepsy through services, education, advocacy and research, so not another moment is lost to seizures. For additional information, please visit http://www.epilepsyfoundation.org.

About ORTHO-McNEIL NEUROLOGICS

Headquartered in Titusville, N.J., ORTHO-McNEIL NEUROLOGICS focuses exclusively on providing solutions that improve neurological health. The company currently markets products for Alzheimer's disease, epilepsy and acute and preventive migraine treatment. ORTHO-McNEIL NEUROLOGICS, in conjunction with internal and external research partners, continues to explore new opportunities to develop solutions for unmet healthcare needs in neurology.

Contacts: Kelli Teno Kara Russell

GolinHarris ORTHO-MCNEIL NEUROLOGICS

312-729-4331 609-730-3592

KTeno@GolinHarris.com KRussel3@prdus.jnj.com


'/>"/>
SOURCE ORTHO-McNEIL NEUROLOGICS
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. AutismOnline.org Partners With Leading Health Communications Firm for Support
2. NYU dental researchers find evidence of periodontal disease leading to gestational diabetes
3. Leading Health Groups Applaud Continued Efforts to Protect Public Health by Ending So-Called Theatrical Productions in Bars
4. Leading Autism Expert Kenneth A. Bock, M.D. Launches National Foundation to Provide Financial Assistance to Children with Autism, Allergies, Asthma and ADHD
5. Australias Leading Juice Company Launches Juice Blend with Marteks lifesDHA(TM)
6. Researchers develop a method to select eggs with the best chance of leading to successful pregnancy
7. Leading researchers honored for progress in cancer prevention, detection and treatment
8. Following School Suicide, National Childrens Charity Issues Tips and Free Resources to Help Prevent 3rd Leading Cause of Death Among Youth
9. Genta Announces Licensing Agreement for Worldwide Development and Commercialization of a Leading Oral Taxane, Tesetaxel
10. Leading Arizona Radiological Group Selects MedQuist for Speech Recognition Solution
11. Leading Health Groups Strongly Support the Minnesota Department of Healths Efforts to Enforce Freedom to Breathe Act
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... May 04, 2016 , ... Slepkow ... up with one of the top website design companies to create a state ... articles related to the law firm's main practice areas. These practice areas include: ...
(Date:5/4/2016)... ... May 04, 2016 , ... Nordic Naturals ... cellular and metabolic health. This synergistic combination of omega-3 fatty acids and potent ... 150 mg of reduced glutathione and 200 mg of N-Acetylcysteine (NAC). , ...
(Date:5/4/2016)... ... 04, 2016 , ... Natalie Jill is a well respected lifestyle ... of the launch of her new book: Natalie Jill’s 7 Day Jump Start: Unprocess ... to jump start a new healthy lifestyle featuring simple recipes using MitoXcell’s raw cacao ...
(Date:5/4/2016)... ... May 04, 2016 , ... Bayco Products has announced the ... dual-light flashlights in models NSP-9842XL and NSR-9844XL . , First previewed at ... uses 2 included CR-123 batteries to produce up to 650 lumens in a ...
(Date:5/4/2016)... (PRWEB) , ... May 04, ... ... next-level compression and support for knees, ankles, and elbows. Engineered with athletes ... Innovative 3D flat-bed manufacturing (opposed to ineffective circular knitting, common in the ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... Valeritas Holdings, Inc. (OTCQB: VLRX) ... offering (APO). This was accomplished via a reverse merger ... a private placement of approximately 5 million shares of ... Under the terms of the reverse merger, which ... will trade on the OTC Markets under the symbol ...
(Date:5/4/2016)... 2016 Research and ... Acute Myeloid Leukemia Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... and Competitive Landscape Highlights 2016, provides comprehensive ... Acute Myeloid Leukemia epidemiology, Acute Myeloid Leukemia ...
(Date:5/3/2016)... India , May 4, 2016 ... spreads across 154 pages, profiling 09 key companies ... is a professional and in-depth study on the ... a basic overview of the industry including definitions, ... Needles market analysis is provided for the international ...
Breaking Medicine Technology: